Network-pharmacology-based research on protective effects and underlying mechanism of Shuxin decoction against myocardial ischemia/reperfusion injury with diabetes

doi:10.4239/wjd.v14.i7.1057

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4322)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-12) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

1782

Figures (1-12)

469

Tables (1-2)

265

Sum=2639

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

201

Download

759

Sum=960

Publishing Process of This Article

Item

Count

Browse

132

Download

426

Sum=558

Jul 15, 2023 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Jul 15, 2023; 14(7): 1057-1076
Published online Jul 15, 2023. doi: 10.4239/wjd.v14.i7.1057

Full Size Figure Download Figure

Figure 10 Pathological staining. A: Hematoxylin and eosin staining; B: Evan’s blue-triphenyltetrazolium chloride double-staining; C: Proportion of areas at risk. ^cP < 0.001 vs group C. ^eP < 0.01, ^fP < 0.001 vs myocardial ischemia/reperfusion injury in diabetes group (n = 3 rats per group). C: Normal control group; DS: Diabetic rats with sham operation group; MI/RI: Myocardial ischemia/reperfusion injury; DMR: MI/RI in diabetes group; SXTL: MI/RI in diabetic rats receiving SXT 0.7 g/kg/d group; SXTM: MI/RI in diabetic rats receiving SXT 1.4 g/kg/d group; SXTH: MI/RI in diabetic rats receiving SXT 2.8 g/kg/d group; AAR: Areas at risk; HE: Hematoxylin and eosin.

Citation: Yang L, Jian Y, Zhang ZY, Qi BW, Li YB, Long P, Yang Y, Wang X, Huang S, Huang J, Zhou LF, Ma J, Jiang CQ, Hu YH, Xiao WJ. Network-pharmacology-based research on protective effects and underlying mechanism of Shuxin decoction against myocardial ischemia/reperfusion injury with diabetes. World J Diabetes 2023; 14(7): 1057-1076
URL: https://www.wjgnet.com/1948-9358/full/v14/i7/1057.htm
DOI: https://dx.doi.org/10.4239/wjd.v14.i7.1057